Tag: Cancer: Cervical
Cervical Adenocarcinoma Rates Increased in Some Populations
Increasing and stabilizing incidence trends seen for several subpopulations; declines attenuated in SCC
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Histologic Clearance of CIN2/3 Seen With HPV Therapeutic Vaccine
In phase II trial, rate of complete resolution of CIN2/3 significantly higher for vaccine versus placebo group
Drop Seen in Preinvasive Cervical Disease With HPV Vaccination
Vaccine effectiveness increased for immunization at younger age
Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
Findings observed regardless of treatment duration; disparities for brachytherapy use seen in vulnerable populations
Decline Observed in HPV Type 16/18 Cervical Precancers in U.S.
Greatest declines seen among vaccinated women; decreases also seen in unvaccinated women
44.4 Million Estimated to Be Diagnosed With Cervical Cancer by 2069
From 2020 to 2069, 6.7 to 7.7 million cases could be averted by scaling up HPV vaccination by 2020
Algorithm Evaluates Cervical Images to ID Precancer, Cancer
Deep learning-based algorithm was validated using archived, digitized cervical screening images
Cervical Cancer Screening Rates ‘Unacceptably Low’
Just 64.6 percent of 30- to 65-year-old women up to date, but Pap-HPV cotesting has increased
HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
HPV-16/18 confers strong future risk, particularly in women younger than 30 years
